Role of Thiamine Supplementation in the Treatment of Chronic Heart Failure: An Updated Meta-Analysis of Randomized Controlled Trials

被引:1
|
作者
He, Shuai [1 ]
Wang, Shasha [2 ]
Xu, Tingli [2 ]
Wang, Shuwei [2 ]
Qi, Minfang [2 ]
Chen, Qingqing [2 ]
Lin, Lu [2 ]
Wu, Huijuan [2 ]
Gan, Pengcheng [2 ]
机构
[1] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Hand & Foot Surg, Taizhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Intens Care Rehabil, Taizhou, Zhejiang, Peoples R China
关键词
cardiac function; chronic heart failure; thiamine; thiamine deficiency; LEFT-VENTRICULAR FUNCTION; CARDIAC-FUNCTION; DOUBLE-BLIND;
D O I
10.1002/clc.24309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundChronic heart failure (CHF) has always posed a significant threat to human survival and health. The efficacy of thiamine supplementation in CHF patients remains uncertain.HypothesisReceiving supplementary thiamine may not confer benefits to patients with CHF.MethodsA comprehensive search was conducted across the Cochrane Library, PubMed, EMBASE, , and Web of Science databases up until May 2023 to identify articles investigating the effects of thiamine supplementation in CHF patients. Predefined criteria were utilized for selecting data on study characteristics and results.ResultsSeven randomized, double-blind, controlled trials (five parallel trials and two crossover trials) involving a total of 274 patients were enrolled. The results of the meta-analysis pooling these studies did not reveal any significant effect of thiamine treatment compared with placebo on left ventricular ejection fraction (WMD = 1.653%, 95% CI: -1.098 to 4.405, p = 0.239, I2 = 61.8%), left ventricular end-diastolic volume (WMD = -6.831 mL, 95% CI: -26.367 to 12.704, p = 0.493, I2 = 0.0%), 6-min walking test (WMD = 16.526 m, 95% CI: -36.582 to 69.634, p = 0.542, I2 = 66.3%), N-terminal pro-B type natriuretic peptide (WMD = 258.150 pg/mL, 95% CI: -236.406 to 752.707, p = 0.306, I2 = 21.6%), or New York Heart Association class (WMD = -0.223, 95% CI: -0.781 to 0.335, p = 0.434, I2 = 87.1%). However, it effectively improved the status of thiamine deficiency (TD).ConclusionsOur meta-analysis indicates that thiamine supplementation does not have a direct therapeutic effect on CHF, except for correcting TD. This meta-analysis aimed to assess the efficacy of thiamine supplementation on parameters including left ventricular ejection fraction, left ventricular end-diastolic volume, 6-min walk test performance, N-terminal pro-B-type natriuretic peptide level, and New York Heart Association class in patients diagnosed with chronic heart failure (CHF). Pooled data analysis did not reveal any significant clinical benefits associated with thiamine intervention. However, it should be noted that thiamine supplementation can effectively address thiamine deficiency in patients with CHF. image
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Impact of Intravenous Iron in patients with heart failure and Iron Deficiency: an updated Meta-analysis of Randomized controlled trials
    Wang, Haiming
    Li, Yanhua
    Zhou, Jingjing
    Wang, Jing
    Shao, Junjie
    Yue, Shuai
    Li, Jiayue
    Guo, Xinhong
    Zhang, Ran
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [32] Efficacy of bevacizumab in the treatment of pterygium: An updated meta-analysis of randomized controlled trials
    Zhang, Xin
    Jiang, Yaping
    Fu, Qiangqiang
    Zhang, Xiaoyan
    Chen, Yihui
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
  • [33] Prognostic benefit of catheter ablation of atrial fibrillation in heart failure: An updated meta-analysis of randomized controlled trials
    Virk, Sohaib A.
    Hyun, Karice
    Brieger, David
    Sy, Raymond W.
    JOURNAL OF ARRHYTHMIA, 2023, 39 (02) : 129 - 141
  • [34] Intravenous iron therapy for patients with heart failure and iron deficiency: an updated meta-analysis of randomized controlled trials
    Ahmed, M.
    Yeap, G.
    Shafiq, A.
    Javaid, H.
    Singh, P.
    Shahbaz, H.
    Maniya, M. T.
    Jain, H.
    Cheema, H. A.
    Ahmad, A.
    Rehman, W. U.
    Minhas, A. B. K.
    Ahmed, R. Raheel
    Fudim, M.
    Fonarow, G. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 593 - 594
  • [35] Efficacy and safety of Guipi Decoction in the treatment of chronic heart failure: A systematic review and meta-analysis of randomized controlled trials
    Rong, Yuanhang
    Wu, Di
    Li, Ming
    Teng, Jing
    MEDICINE, 2023, 102 (09) : E33181
  • [36] Arginine vasopressin antagonist tolvaptan in the treatment of heart failure: a meta-analysis of randomized controlled trials
    Yang, Chao-Jun
    Yang, Jun
    Yang, Jian
    Fan, Zhi-Xing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (12): : 22117 - 22128
  • [37] Catheter ablation of atrial fibrillation with heart failure: An updated meta-analysis of randomized trials
    Kheiri, Babikir
    Osman, Mohammed
    Abdalla, Ahmed
    Haykal, Tarek
    Ahmed, Sahar
    Bachuwa, Ghassan
    Hassan, Mustafa
    Bhatt, Deepak L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 269 : 170 - 173
  • [38] Growth hormone treatment in children with chronic renal failure: A meta-analysis of randomized controlled trials
    Vimalachandra, D
    Craig, JC
    Cowell, CT
    Knight, JF
    JOURNAL OF PEDIATRICS, 2001, 139 (04): : 560 - 567
  • [39] B-TYPE NATRIURETIC PEPTIDE-GUIDED TREATMENT FOR PATIENTS WITH HEART FAILURE: A UPDATED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Qiao, Z.
    CHEST, 2020, 157 (06) : 117A - 117A
  • [40] Meta-analysis of vitamin D supplementation in the treatment of chronic heart failure
    Wang, Ting
    Liu, Zhenguo
    Fu, Jianli
    Min, Zhiqian
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2019, 53 (03) : 110 - 116